S&P 500
(0.12%) 5 303.27 points

Dow Jones
(0.34%) 40 004 points

Nasdaq
(-0.07%) 16 686 points

Oil
(0.04%) $80.09

Gas
(1.79%) $2.67

Gold
(0.94%) $2 440.20

Silver
(3.71%) $32.42

Platinum
(0.87%) $1 099.50

USD/EUR
(-0.08%) $0.919

USD/NOK
(-0.14%) $10.66

USD/GBP
(-0.02%) $0.787

USD/RUB
(0.09%) $91.05

Realtime updates for Bristol-Myers Squibb Co [BRM.DE]

Exchange: XETRA Sector: Pharmaceuticals Industry: Drug Manufacturers—General

Last Updated17 May 2024 @ 11:43

25% discount on Stockinvest.us - Use code: Podcast

0.14% € 40.30

Live Chart Being Loaded With Signals

Commentary (17 May 2024 @ 11:43):

Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases...

Stats
Today's Volume	8 007.00
Average Volume	2 999.00
Market Cap	81.68B
EPS	€0 ( 2024-04-25 )
Next earnings date	( €0 ) 2024-07-26
Last Dividend	€0.570 ( 2023-07-06 )
Next Dividend	€0 ( N/A )
P/E	-14.14
ATR14	€0.0650 (0.16%)

Bristol-Myers Squibb Co Correlation

10 Most Positive Correlations

10 Most Negative Correlations

Did You Know?

Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).

Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.

Bristol-Myers Squibb Co Financials

Annual	2023
Revenue:	€45.01B
Gross Profit:	€34.31B (76.24 %)
EPS:	€3.88

FY	2023
Revenue:	€45.01B
Gross Profit:	€34.31B (76.24 %)
EPS:	€3.88

FY	2022
Revenue:	€46.16B
Gross Profit:	€36.02B (78.04 %)
EPS:	€2.97

FY	2021
Revenue:	€46.39B
Gross Profit:	€36.45B (78.57 %)
EPS:	€3.15

Financial Reports:

No articles found.

Bristol-Myers Squibb Co Dividends

(Q3/22)	(Q4/22)	(Q1/23)	(Q2/23)	(Q3/23)	(Q4/23)	(Q1/24)	(Q2/24)	(Q3/24)	(Q4/24)
€0 (N/A)	€0.540 (N/A)	€0.570 (N/A)	€0.570 (N/A)	€0.570 (N/A)	€0 (N/A)	€0 (N/A)	€0 (N/A)	€0 (N/A)	€0 (N/A)

Bristol-Myers Squibb Co Dividend Information - Ex Dividend Knight

Dividend Sustainability Score: 6.02 - average (67.70%) | Divividend Growth Potential Score: 0.751 - No dividend expected

Very Unsafe

High risk of being cut

Unsafe

Heightened risk of being cut

Borderline

Moderate risk of being cut

Safe

Unlikely to be cut

Very Safe

Very unlikely to be cut

Information

First Dividend	€0.215	1999-06-30
Last Dividend	€0.570	2023-07-06
Next Dividend	€0	N/A
Payout Date	0000-00-00
Next Payout Date	N/A
# dividends	97	--
Total Paid Out	€33.94	--
Avg. Dividend % Per Year	0.00%	--
Score	3.49	--
Div. Sustainability Score	6.02
Div.Growth Potential Score	0.751
Div. Directional Score	3.39	--

Next Divdend (Est)
(2024-08-20)

€0.580 Estimate 21.49 %

Dividend Stability

0.57 Average

Dividend Score

3.49

Pay Frequency

Quarterly

Yearly Payout

Year	Amount	Yield

Dividend Commentary

With a moderate Dividend Sustainability Score (DSS), the company may sustain its dividends, but continuous monitoring is advised for any financial shifts. Unfortunately, its low Dividend Growth Potential Score (DGPS) suggests limited prospects for dividend growth. In conclusion, a more vigilant stance is recommended given the company's tentative dividend landscape.

Top 10 dividend Companies for XETRA

Symbol	Title	Last dividend	Frequency	Years Dividend	Yearly Dividend	Score
OMV.DE	Ex Dividend Knight	2023-06-06	Annually	0	0.00%
FC9.DE	Ex Dividend Junior	2023-06-14	Annually	0	0.00%
SII.DE	Ex Dividend Knight	2023-08-24	Quarterly	0	0.00%
5Y7.F	Ex Dividend Knight	2023-08-08	Semi-Annually	0	0.00%
HRS.DE	Ex Dividend Knight	2023-09-01	Quarterly	0	0.00%
VFP.DE	Ex Dividend Junior	2023-09-08	Quarterly	0	0.00%
ASME.DE	Ex Dividend Knight	2023-08-01	Semi-Annually	0	0.00%
LOM.DE	Ex Dividend Knight	2023-08-31	Quarterly	0	0.00%
CRZK.DE	Ex Dividend Junior	2023-07-17	Annually	0	0.00%
ENL.DE	Ex Dividend Knight	2023-07-24	Semi-Annually	0	0.00%

Dividend Sustainability Score (DSS)

Ratio	Actual Value	Weight	Normalized Value	Score	Range
netProfitMarginTTM	-0.135	1.500	-2.70	-4.05	[0 - 0.5]
returnOnAssetsTTM	-0.0621	1.200	-2.07	-2.48	[0 - 0.3]
returnOnEquityTTM	-0.230	1.500	-3.67	-5.50	[0.1 - 1]
payoutRatioTTM	-0.774	-1.000	-7.74	7.74	[0 - 1]
currentRatioTTM	1.110	0.800	9.45	7.56	[1 - 3]
quickRatioTTM	0.919	0.800	9.30	7.44	[0.8 - 2.5]
cashRatioTTM	0.361	1.500	9.10	10.00	[0.2 - 2]
debtRatioTTM	0.580	-1.500	0.338	-0.507	[0 - 0.6]
interestCoverageTTM	6.80	1.000	8.59	8.59	[3 - 30]
operatingCashFlowPerShareTTM	6.78	2.00	7.74	10.00	[0 - 30]
freeCashFlowPerShareTTM	6.18	2.00	6.91	10.00	[0 - 20]
debtEquityRatioTTM	3.48	-1.500	10.00	-10.00	[0 - 2.5]
grossProfitMarginTTM	0.757	1.000	0.715	0.715	[0.2 - 0.8]
operatingProfitMarginTTM	0.195	1.000	8.11	8.11	[0.1 - 0.6]
cashFlowToDebtRatioTTM	0.239	1.000	9.78	9.78	[0.2 - 2]
assetTurnoverTTM	0.460	0.800	-0.268	-0.214	[0.5 - 2]
Total Score				6.02

Dividend Growth Score (DGS)

Ratio	Actual Value	Weight	Normalized Value	Score	Range
peRatioTTM	-14.42	1.000	-1.557	0	[1 - 100]
returnOnEquityTTM	-0.230	2.50	-2.36	-5.50	[0.1 - 1.5]
freeCashFlowPerShareTTM	6.18	2.00	7.94	10.00	[0 - 30]
dividendYielPercentageTTM	2.56	1.500	10.00	0	[0 - 0.4]
operatingCashFlowPerShareTTM	6.78	2.00	7.74	10.00	[0 - 30]
payoutRatioTTM	-0.774	1.500	-7.74	7.74	[0 - 1]
pegRatioTTM	-0.772	1.500	-8.48	0	[0.5 - 2]
operatingCashFlowSalesRatioTTM	0.301	1.000	4.96	0	[0.1 - 0.5]
Total Score				0.751

Bristol-Myers Squibb Co Options Data

Calls

Contract Name	Last Trade Date (EDT)	Strike	Last Price	Bid	Ask	Change	% Change	Volume	Open Interest	Implied Volatility	Strike Date
No data available

Puts

Contract Name	Last Trade Date (EDT)	Strike	Last Price	Bid	Ask	Change	% Change	Volume	Open Interest	Implied Volatility	Strike Date
No data available

Bristol-Myers Squibb Co

Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple myeloma; Eliquis, an oral inhibitor for reduction in risk of stroke/systemic embolism in NVAF, and for the treatment of DVT/PE; Opdivo for anti-cancer indications; Pomalyst/Imnovid indicated for patients with multiple myeloma; and Orencia for adult patients with active RA and psoriatic arthritis. It also provides Sprycel for the treatment of Philadelphia chromosome-positive chronic myeloid leukemia; Yervoy for the treatment of patients with unresectable or metastatic melanoma; Abraxane, a protein-bound chemotherapy product; Reblozyl for the treatment of anemia in adult patients with beta thalassemia; and Empliciti for the treatment of multiple myeloma. In addition, the company offers Zeposia to treat relapsing forms of multiple sclerosis; Breyanzi, a CD19-directed genetically modified autologous T cell immunotherapy for the treatment of adult patients with relapsed or refractory large B-cell lymphoma; Inrebic, an oral kinase inhibitor indicated for the treatment of adult patients with myelofibrosis; and Onureg for the treatment of adult patients with AML. It sells products to wholesalers, distributors, pharmacies, retailers, hospitals, clinics, and government agencies. The company was formerly known as Bristol-Myers Company. The company was founded in 1887 and is headquartered in New York, New York.

About Live Signals

The live signals presented on this page help determine when to BUY or SELL NA. The signals have upwards of a 1-minute delay; like all market signals, there is a chance for error or mistakes.

The live trading signals are not definite, and getagraph.com hold no responsibility for any action taken upon these signals, as described in the Terms of Use. The signals are based on a wide range of technical analysis indicators

Investing in the stock market involves risk and the value of your investment can fluctuate. The stock market can be affected by a variety of factors, including economic conditions, company performance, and global events. There is no guarantee of profit and you could lose money. Please consider your financial situation, investment goals, and level of risk tolerance before making any investment decisions. Consult with a financial advisor for personalized advice.